New therapy aims to ease chronic ankle pain without surgery
NCT ID NCT07449078
First seen Mar 13, 2026 · Last updated Jun 08, 2026 · Updated 10 times
Summary
This study tests a therapy called Cognitive Functional Therapy (CFT) for people with chronic ankle sprain—ongoing pain, instability, or fear of moving the ankle. About 40 adults aged 18–65 with symptoms lasting over 3 months will receive CFT to see if it reduces pain, improves daily function, and lessens fear of movement. The goal is to offer a non-surgical option for long-term ankle problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ANKLE SPRAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yeditepe University
RECRUITINGIstanbul, Ataşehir, 34775, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.